[1]
|
Lea, R.A., Ovcaric, M., Sundholm, J., MacMillan, J. and Griffiths, L.R. (2004) The Methylenetetrahydrofolate Reductase Gene C677t Influences Susceptibility to Migraine with Aura. BMC Medicine, 2, 3-7. https://doi.org/10.1186/1741-7015-2-3
|
[2]
|
Haut, S.R., Bigal, M.E. and Lipton, R.B. (2006) Chronic Disorders with Episodic Manifestations: Focus on Epilepsy and Migraine. The Lancet Neurology, 5, 148-157.
|
[3]
|
Silberstein, S.D. (2004) Migraine. The Lancet, 363, 381-391.
|
[4]
|
World Health Organization (2011) Atlas of Headache Disorders and Resources in the World 2011. World Health Organization, Geneva.
|
[5]
|
Stewart, W.F., Lipton, R.B., Celentano, D.D. and Reed, M.L. (1992) Prevalence of Migraine Headache in the United States. Relation to Age, Income, Race, and Other Sociodemographic Factors. JAMA, 267, 64-69.
https://doi.org/10.1001/jama.1992.03480010072027
|
[6]
|
Lipton, R.B., Bigal, M.E., Diamond, M., Freitag, F., Reed, M.L. and Stewart, W.F. (2007) AMPP Advisory Group. Migraine Prevalence, Disease Burden, and the Need for Preventive Therapy. Neurology, 68, 343-349.
https://doi.org/10.1212/01.wnl.0000252808.97649.21
|
[7]
|
Lipton, R.B., Stewart, W.F., Diamond, S., Diamond, M.L. and Reed, M. (2001) Prevalence and Burden of Migraine in the United States, Data from the American Migraine Study II. Headache, 41, 646-657.
https://doi.org/10.1046/j.1526-4610.2001.041007646.x
|
[8]
|
Wang, S.J. (2003) Epidemiology of Migraine and Other Types of Headache in Asia. Current Neurology and Neuroscience Reports, 3, 104-108.
https://doi.org/10.1007/s11910-003-0060-7
|
[9]
|
Chiodini, B.D., Barlera, S., Franzosi, M.G. and Rognoni, G.I. (2001) Geni di suscettibilità all’infarto, una revisione della letteratura. Italian Heart Journal, 2, 935-944.
|
[10]
|
Colucci d’Amato, C., Alfano, V., Giordano, E., Marmolo, T. and Pizza, V. (1997) Le Cefalee. 2nd Edition, Idelson, Napoli.
|
[11]
|
Bianchi, A., Pitari, G., Amenta, V., Giuliano, F., Gallina, M., Costa, R. and Ferlito, S. (1996) Endothelial, Haemostatic and Haemorheological Modifications in Migraineurs. Artery, 22, 93-100.
|
[12]
|
Corral, J., Iniesta, J.A., Gonzà-Conejero, R., Lozano, M.L., Rivera, J. and Vicente, V. (1998) Migraine and Prothrombotic Genetic Risk Factors. Cephalalgia, 18, 257.
https://doi.org/10.1046/j.1468-2982.1998.1805257.x
|
[13]
|
Colson, N.J., Fernandez, F. and Griffiths, L.R. (2007) Migraine Genetics and Prospects for Pharmacotherapy. Drug Development Research, 68, 282-293.
https://doi.org/10.1002/ddr.20192
|
[14]
|
Peroutka, S.J. (1997) Dopamine and Migraine. Neurology, 49, 650-656.
https://doi.org/10.1212/WNL.49.3.650
|
[15]
|
Frosst, P., Blom, H.J., Milos, R., Goyette, P., Sheppard, C.A., Matthews, R.G., Boers, G.J., den Heijer, M., Kluijtmans, L.A. and van den Heuvel, L.P. (1995) A Candidate Genetic Risk Factor for Vascular Disease, a Common Mutation in Methylenetetrahydrofolate Reductase. Nature Genetics, 10, 111-113.
https://doi.org/10.1038/ng0595-111
|
[16]
|
Headache Classification Committee of the International Headache Society (IHS) (2013) The International Classification of Headache Disorders. 3rd Edition, Beta Version, Cephalalgia, 33, 629-808.
|
[17]
|
Cicek, M.S., Nock, N.L., Li, L., Conti, D.V., Casey, G. and Witte, J.S. (2004) Relationship between Methylenetetrahydrofolate Reductase C677T and A1298C Genotypes and Haplotypes and Prostate Cancer Risk and Aggressiveness. Cancer Epidemiology, Biomarkers & Prevention, 13, 1331-1336.
|
[18]
|
Lipton, R.B. and Bigal, M.E. (2005) The Epidemiology of Migraine. American Journal of Medicine, 118, 3S-10S.
|
[19]
|
Mulder, E.J., Van Baal, C., Gaist, D., Kallela, M., Kaprio, J., Svensson, D.A., Nyholt, D.R., Martin, N.G., MacGregor, A.J., Cherkas, L.F., Boomsma, D.I. and Palotie, A. (2003) Genetic and Environmental Influences on Migraine, a Twin Study across Six Countries. Twin Research, 6,422-431. https://doi.org/10.1375/136905203770326420
|
[20]
|
Tietjen, E.G. (2007) Migraine and Ischaemic Heart Disease and Stroke, Potential Mechanisms and Treatment Implications. Cephalalgia, 27, 981-987.
https://doi.org/10.1111/j.1468-2982.2007.01407.x
|
[21]
|
Joshi, G., Pradhan, S. and Mittal, B. (2009) Role of the ACE ID and MTHFR C677T Polymorphisms in Genetic Susceptibility of Migraine in a North Indian Population. Journal of the Neurological Sciences, 277, 133-137.
|
[22]
|
Cakmak, E.A., Cataloluk, O., Yoldas, T., Herken, H. and Barlas, O. (2003) Migraine and Angiotensinconverting Enzyme Association in Turkish Patients. Pain Clinics, 15, 473-477. https://doi.org/10.1163/156856903770196881
|
[23]
|
Kara, I., Ozkok, E., Aydin, M., Orhan, N., Cetinkaya, Y., Gencer, M., Kilic, G. and Tireli, H. (2007) Combined Effects of ACE and MMP-3 Polymorphisms on Migraine Development. Cephalalgia, 27, 235-243.
https://doi.org/10.1111/j.1468-2982.2006.01269.x
|
[24]
|
Kowa, H., Fusayasu, E., Ijiri, T., Ishizaki, K., Yasui, K., Nakaso, K., Kusumi, M., Takeshima, T. and Nakashima, K. (2005) Association of the Insertion/Deletion Polymorphism of the Angiotensin I-Converting Enzyme Gene in Patients of Migraine with Aura. Neuroscience Letters, 374, 129-131.
|
[25]
|
Lea, R.A., Ovcaric, M., Sundholm, J., Solyom, L., Macmillan, J. and Griffiths, L.R. (2005) Genetic Variants of Angiotensin Converting Enzyme and Methylenetetrahydrofolate Reductase May Act in Combination to Increase Migraine Susceptibility. Brain Research. Molecular Brain Research, 136, 112-117.
|
[26]
|
Lin, J.J., Wang, P.J., Chen, C.H., Yueh, K.C., Lin, S.Z. and Harn, H.J. (2005) Homozygous Deletion Genotype of Angiotensin Converting Enzyme Confers Protection against Migraine in Man. Acta Neurologica Taiwanica, 14, 120-125.
|
[27]
|
Paterna, S., Di Pasquale, P., D’Angelo, A., Seidita, G., Tuttolomondo, A., Cardinale, A., Maniscalchi, T., Follone, G., Giubilato, A., Tarantello, M. and Licata, G. (2000) Angiotensin Converting Enzyme Gene Deletion Polymorphism Determines an Increase in Frequency of Migraine Attacks in Patients Suffering from Migraine without Aura. European Neurology, 43, 133-136. https://doi.org/10.1159/000008151
|
[28]
|
Schürks, M., Zee, R.Y.L., Buring, J.E. and Kurth, T. (2009) ACE D/I Polymorphism, Migraine, and Cardiovascular Disease in Women. Neurology, 72, 650-656.
https://doi.org/10.1212/01.wnl.0000342517.97178.f6
|
[29]
|
Tronvik, E., Stovner, L.J., Bovim, G., White, L.R., Gladwin, A.J., Owen, K. and Schrader, H. (2008) Angiotensin Converting Enzyme Gene Insertion/Deletion Polymorphism in Migraine Patients. BMC Neurology, 8, 4.
https://doi.org/10.1186/1471-2377-8-4
|
[30]
|
Kurth, T., Gaziano, J.M., Cook, N.R., Logroscino, G., Diener, H.C. and Buring, J.E. (2006) Migraine and Risk of Cardiovascular Disease in Women. JAMA, 296, 283-291. https://doi.org/10.1001/jama.296.3.283
|
[31]
|
Kara, I., Sazei, A., Ergul, E., Kaya, G. and Kilie, G. (2003) Association of the C677T and A1298C Polymorphisms in the 5, 10 Methylenetetrahy-drofolate Reductase Gene in Patients with Migraine Risk. Brain Research. Molecular Brain Research, 111, 84-90.
|
[32]
|
Todt, U., et al. (2006) MTHFR C677T Polymorphism and Migraine with Aura. Annals of Neurology, 60, 621-622.
|
[33]
|
Kaunisto, M.A., Kallela, M., Hämäläinen, E., Kilpikari, R., Havanka, H., Harno, H., Nissilä, M., Säkö, E., Ilmavirta, M., Liukkonen, J., Teirmaa, H., Törnwall, O., Jussila, M., Terwilliger, J., Färkkilä, M., Kaprio, J., Palotie, A. and Wessman, M. (2006) Testing of Variants of the MTHFR and ESR1 Genes in 1798 Finnish Individuals Fails to Confirm the Association with Migraine with Aura. Cephalalgia, an International Journal of Headache, 26, 1462-1472.
|
[34]
|
Kowa, H., Yasui, K., Takeshima, T., Urakami, K., Sakai, F. and Nakashima, K. (2000) The Homozygous C677T Mutation in the Methylenetetrahydrofolate Reductase Gene Is a Genetic Risk Factor for Migraine. American Journal of Medical Genetics, 96, 762-764.
https://doi.org/10.1002/1096-8628(20001204)96:6<762::AID-AJMG12>3.0.CO;2-X
|
[35]
|
Lea, R.A., Ovcaric, M., Sundholm, J., MacMillan, J. and Griffiths, L.R. (2004) The Methylenetetrahydrofolate Reductase Gene Variant C677T Influences Susceptibility to Migraine with Aura. BMC Medicine, 2, 3. https://doi.org/10.1186/1741-7015-2-3
|
[36]
|
Scher, A.I., Terwindt, G.M., Verschuren, W.M., Kruit, M.C., Blom, H.J., Kowa, H., Frants, R.R., van den Maagdenberg, A.M., van Buchem, M., Ferrari, M.D. and Launer, L.J. (2006) Migraine and MTHFR C677T Genotype in a Population-Based Sample. Annals of Neurology, 59, 372-375. https://doi.org/10.1002/ana.20755
|
[37]
|
Oterino, A., Valle, N., Bravo, Y., Muñoz, P., Sánchez-Velasco, P., Ruiz-Alegría, C., Castillo, J., Leyva-Cobián, F., Vadillo, A. and Pascual, J. (2004) MTHFR T677 Homozygosis Influences the Presence of Aura in Migraineurs. Cephalalgia, an International Journal of Headache, 24, 491-494.
|
[38]
|
Bottini, F., Celle, M.E., Calevo, M.G., Amato, S., Minniti, G., Montaldi, L., Di Pasquale, D., Cerone, R., Veneselli, E. and Molinari, A.C. (2006) Metabolic and Genetic Risk Factors for Migraine in Children. Cephalalgia, 26, 731-737.
https://doi.org/10.1111/j.1468-2982.2006.01107.x
|
[39]
|
Rubino, E., Ferrero, M., Rainero, I., Binello, E., Vaula, G. and Pinessi, L. (2007) Association of the C677T Polymorphism in the MTHFR Gene with Migraine, a Meta-Analysis. Cephalalgia, 29, 818-825.
https://doi.org/10.1111/j.1468-2982.2007.01400.x
|
[40]
|
Ferro, A., Castro, M.J., Lemos, C., Santos, M., Sousa, A., Pereira-Monteiro, J., et al. (2008) The C677T Polymorphism in MTHFR Is Not Associated with Migraine in Portugal. Disease Markers, 25, 107-113. https://doi.org/10.1155/2008/178679
|
[41]
|
Pietrobon, D. and Striessnig, J. (2003) Neurobiology of Migraine. Nature Reviews Neuroscience, 4, 386-398. https://doi.org/10.1038/nrn1102
|